AKAM vs CAH · P/E 27, rev $2.17B vs P/E 35, rev $254.25B
Akamai Technologies Inc (AKAM) versus Cardinal Health Inc (CAH) — a side-by-side from cached financials, not a winner call.
Akamai Technologies Inc (AKAM) is a software - infrastructure company listed on US.
Cardinal Health Inc (CAH) is a medical distribution company listed on NYSE.
Latest reported AKAM revenue for 2026-06-30 was $2.17B. Net income was $185.7M. AKAM currently screens at market cap $11.31B and trailing P/E 26.7.
Latest reported CAH revenue for 2026-06-30 was $254.25B. Net income was $1.71B. Revenue was up 14.2% from 2025-06-30 to 2026-06-30. CAH currently screens at market cap $53.00B and trailing P/E 34.6.
AKAM currently screens at market cap $11.31B and trailing P/E 26.7. CAH currently screens at market cap $53.00B and trailing P/E 34.6.
Not investment advice. Open the AKAM and CAH stock pages for the full models.
Not investment advice.